Abdel Gaffar Mohammed/X
Sep 7, 2026, 23:56
Abdel Gaffar Mohammed: Treatment Approaches for Different Types of TMA
Abdel Gaffar Mohammed, IM/Rheumatology consultant at KAH, shared a post on X:
“TMA Treatment Lupus-TTP and APS-TMA are treated with combinations of plasma exchange, high-dose glucocorticoids, rituximab, and anticoagulation.
Complement-mediated TMA relies on targeted complement inhibition (eculizumab or ravulizumab) as the cornerstone of therapy.”
Stay updated with Hemostasis Today.
-
Oct 23, 2026, 07:17Nahush Chafekar: Anticoagulation Strategies in Haemodialysis Patients with AF
-
Oct 23, 2026, 07:15Jessica Garcia: Honored Among the Best Doctors of 2026
-
Oct 23, 2026, 07:07Reda Awad Abdelsalam: FXIa Inhibition for Stroke Prevention
-
Oct 23, 2026, 06:43Tim Blair: Improving DVT Awareness, Early Diagnosis, and Access to Treatment
-
Oct 22, 2026, 18:04Basem Goueli: Blood Clots in the NFL
-
Oct 22, 2026, 17:57Syed Ahmed: Viral Triggers of Immune Thrombocytopenia and Thrombosis
-
Oct 22, 2026, 17:49Valerie Tutwiler: Bridging Engineering and Medicine to Advance Thrombosis Research
-
Oct 22, 2026, 17:41Jesus Ardila Novoa: How Patient Education Can Transform Hemophilia Care
-
Oct 22, 2026, 17:30Filipe Gonçalves: Advancing Bleeding Disorder Diagnosis Through Multidisciplinary Collaboration